Table 2 Clinical features of myoid gonadal stromal tumors—comparison with other testicular tumor entities
Testicular tumor entity | Data abstracted from | (n) | Age, median (years) | IQR | tumor size, median (mm) | IQR | Laterality right sided | TSS |
|---|---|---|---|---|---|---|---|---|
Myoidal gonadal stromal tumor | Present report | 23 | 37 | 24; 45 | 20 | 11; 31 | 50% | 10% |
Leydig cell tumors | Ruf 2020 [25] | 208 | 41 | 33; 48 | 12.5 | 7; 20 | 51.5% | 56% |
Sertoli cell tumor | Grogg 2020a [4] | 435 | 29 | 16; 44 | 20 | 12.5; 39 | NA | 13% |
Adult granulosa cell tumors | Dieckmann 2019a [5] | 91 | 44 | 26; 55 | 32 | 15; 50 | 45.7% | 3% |
All benign testicular tumors | Hamburg 2022b [26] | 79 | 41 | 32; 50 | 10 | 6; 15 | NA | NA |
Testicular seminoma | Hamburg 2022b [26] | 365 | 40 | 33; 48 | 30 | 19; 46 | 53.5%c | Isolated cases |
Testicular nonseminoma | Hamburg 2022b [26] | 179 | 31 | 26; 37 | 35 | 20; 49 | 45%c | Isolated cases |
Other malignant testicular tumors | Hamburg 2022b [26] | 18 | 72.5 | 68; 78 | 53 | 49; 56 | NA | 0% |